People In The News

NEW YORK (GenomeWeb News) - Compugen said this week that Anat Cohen-Dayag and Martin Gerstel will serve as co-CEOs of the company. Cohen-Dayag started with the company in 2002, and she has served as VP for diagnostic biomarkers and drug targets. Before starting at Compugen, she was head of R&D at Mindsense Biosystems.

Gerstel began at Compugen in 1997 as chairman and was appointed president and CEO earlier this year. Before joining Compugen, Gerstel was co-chairman and CEO of ALZA Corporation and a director of the Pharmaceutical Research and Manufacturers of America.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.